Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Genitourinary 2Sarcoma 1Lymphoid 1Gynecologic 1Gastrointestinal 1Endocrine 1CNS 1Breast 1

Conditions

Carcinoma, Renal Cell 9Prostatic Neoplasms 8Breast Neoplasms 7Urinary Bladder Neoplasms 6Stomach Neoplasms 5Carcinoma, Transitional Cell 5Brain Neoplasms 4Testicular Neoplasms 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Kidney Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Neuroendocrine Tumors 2Mesothelioma 2Melanoma 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Adrenal Gland Neoplasms 2von Hippel-Lindau Disease 1Vaginal Neoplasms 1Uterine Neoplasms 1

Interventions

pembrolizumab 9Nivolumab 5tislelizumab 2spartalizumab 2belinostat 2atezolizumab 2Pemetrexed 2Paclitaxel 2Ipilimumab 2Fluorodeoxyglucose F18 2Docetaxel 2Cisplatin 2tocilizumab 1sargramostim 1obinutuzumab 1niraparib 1naptumomab estafenatox 1milademetan 1epacadostat 1enzalutamide 1durvalumab 1cabozantinib 1bosutinib 1Sorafenib 1Sirolimus 1Quality of Life 1Plicamycin 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mesothelioma × Fluorodeoxyglucose F18 × Genitourinary × Clear all
NCT06503146 2026-05-19

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
320 enrolled
CNSEndocrineGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT02599194 2019-01-03

18F-FSPG PET/CT for Cancer Patients on Therapy

Stanford University

Phase 2 Completed
7 enrolled 6 charts
BreastGenitourinaryLymphoidOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Lymphoma, B-Cell, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡